Gold Road Resources Ltd
SWB:E6Q
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gold Road Resources Ltd
SWB:E6Q
|
AU |
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
Nampak Ltd
F:NNZ0
|
ZA |
|
Alphamin Resources Corp
XTSX:AFM
|
MU |
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
A
|
Arafura Resources Ltd
F:REB
|
AU |
|
F
|
Fuji Media Holdings Inc
F:FTN
|
JP |
|
DocuSign Inc
NASDAQ:DOCU
|
US |
|
A
|
Asahi Holdings Inc
XBER:A19
|
JP |
|
B
|
Barco NV
OTC:BCNAY
|
BE |
|
B
|
BP PLC
F:BPE5
|
UK |
|
V
|
Viad Corp
F:DIL1
|
US |
|
C
|
CCL Industries Inc
OTC:CCDBF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is E6Q's stock price target?
Not Available
E6Q does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Gold Road Resources Ltd?
Projected CAGR
20%
The compound annual growth rate for Revenue over the next 3 years is 20%.
What is the Operating Income forecast for Gold Road Resources Ltd?
Projected CAGR
29%
The compound annual growth rate for Operating Income over the next 3 years is 29%.